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Agtr2Intellectual disability (ID) is a common developmental disability observed in 1 to 3% of the human
population. A possible role for the Angiotensin II type 2 receptor (AGTR2) in brain function, affecting
learning, memory, and behavior, has been suggested in humans and rodents. Mice lacking the Agtr2 gene
(Agtr2−/y) showed signiﬁcant impairment in their spatial memory and exhibited abnormal dendritic spine
morphology. To identify Agtr2 inﬂuenced genes and pathways, we performed whole genome microarray
analysis on RNA isolated from brains of Agtr2−/y and control male mice at embryonic day 15 (E15) and
postnatal day one (P1). The gene expression proﬁles of the Agtr2−/y brain samples were signiﬁcantly
different when compared to proﬁles of the age-matched control brains. We identiﬁed 62 differently
expressed genes (p≤0.005) at E15 and in P1 brains of the Agtr2−/y mice. We veriﬁed the differential
expression of several of these genes in brain samples using quantitative RT-PCR. Differentially expressed
genes encode molecules involved in multiple cellular processes including microtubule functions associated
with dendritic spine morphology. This study provides insight into Agtr2 inﬂuenced candidate genes and
suggests that expression dysregulation of these genes may modulate Agtr2 actions in the brain that
inﬂuences learning and memory.© 2009 Elsevier Inc. All rights reserved.IntroductionIntellectual disability (ID), also known as mental retardation, is a
genetically and clinically heterogeneous condition characterized by
below average intellectual functioning (IQb70) in conjunction with
signiﬁcant limitations in adaptive functioning. The genetic component
of ID likely includes deﬁciencies in the function of a large number of
genes distributed throughout the human genome [1].
Angiotensin II (Ang II), a component of the renin–angiotensin
system (RAS), mediates its majority of functions through two major
Ang II receptor subtypes, type 1 receptor (AGTR1) and type 2 receptor
(AGTR2). Studies in mice and humans indicated a possible role for
AGTR2 in learning, memory, and behavior [2–6]. Neurological ﬁndingsf Human Genetics, Greenwood
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eering, University of California
es, Hull York Medical School,
ll rights reserved.in Agtr2-deﬁcient male mice (Agtr2−/y) provided an initial hypothesis
of a likely role for Agtr2 in the brain [7,8]. Recently, a detailed
examination of the Agtr2-deﬁcient mice revealed signiﬁcant impair-
ment in their learning performance in a spatial memory task [9]. These
mice exhibited abnormal dendritic spine morphology [9], a feature
previously shown to be associated with several cases of ID [10–12].
AGTR2 is a 323-residue G-protein-coupled receptor transcribed
from an X-linked gene. Expression of the Agtr2 gene has been shown
to be transiently expressed in the mesenchyme of the rat fetus, in
various brain structures through embryonic development, with its
expression declining rapidly after birth and becoming restricted to a
few organs including the brain [13]. At the cellular level, Agtr2 has
been shown to be localized in neurons [14]. Involvement of Agtr2 in
several signaling cascades inﬂuencing neurite outgrowth and elonga-
tion, neuronal differentiation, cell proliferation, growth inhibition
and induction of apoptosis has emerged in recent years but none is
fully deﬁned. Several proteins, avian erythroblastosis oncogene B 3
receptor (ERBB3), zinc ﬁnger and BTB domain containing 16 (ZBTB16),
solute carrier family 9 (sodium/hydrogen exchanger), member 6
(NHE6/SLC9A6), and mitochondrial tumor suppressor 1 (MTUS1),
have been found to interact with regions of AGTR2 [15–18].
Interestingly, defects in the NHE6/SLC9A6 gene have recently been
found to cause Christianson syndrome, an X-linked ID condition [19].
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dysregulated genes and pathways relevant to Agtr2 function, we
proﬁled gene expression patterns of Agtr2−/y brains at developmental
stage E15 and at birth and compared them to proﬁles of the age-
matched control brains. This study revealed a number of candidate
genes and cellular processes that may potentially inﬂuence brain
structure and function critical for learning and memory.
Results
Microarray analysis
Expression microarray analysis was performed using RNA isolated
from brains of male Agtr2-deﬁcient (Agtr2−/y) and control mice of
identical genetic background using Agilent whole mouse genome 44K
expression arrays. Gene expression proﬁles of the Agtr2−/y brain
samples were compared to proﬁles of the control brains for two
developmental stages, E15 and birth (P1). Multiple biological
replicates (eight Agtr2−/y and six control brains at E15 and four
Agtr2−/y and four control brains at birth) were analyzed individually
using a dye swap experimental design. The raw data were analyzed as
detailed in the Materials and methods. Hierarchical clustering of each
developmental set demonstrated that, overall, the Agtr2−/y mouseFig. 1. Hierarchical clustering showing knockout animals have different expression proﬁles
branches being the control group and yellow the Agtr2−/y group. Each row is a probe, each co
down-regulation. Gray represents lack of hybridization. (A) Embryo (E15) arrays (B) postn
represented by a different color on the tree branches. A gene tree is on the left side of eachbrains had signiﬁcantly different expression patterns than controls
(Fig. 1).
Data analysis revealed 62 differently expressed genes (52 up-
regulated and 10 down-regulated, p≤0.005) (Table 1). A similar
analysis in P1 brains resulted in a list of 50 up-regulated and 12 down-
regulated genes (Table 2) identiﬁed with a fold change greater than or
equal to 1.4 and p-value less than 0.005. Fold change was computed
with Bioconductor limma software with a log2 transformation. Two
genes, phosphatidylserine decarboxylase (Pisd) and RAB30, member
RAS oncogene family (Rab30), were found to be up-regulated at both
developmental stages (Tables 1 and 2).
We further validated the differential expression of a subset of
genes identiﬁed bymicroarray analysis using an independent method.
We performed quantitative real-time PCR analysis of transcripts
randomly selected from the E15 list (Table 1) and P1 list (Table 2).
Changes in expression of these genes in Agtr2−/y brain samples
relative to control brains were in agreement with the direction of the
expression proﬁle array data (Table 3). Four genes tested were
signiﬁcantly (p≤0.05) differentially expressed by qRT-PCR. The
expression of seven other genes were comparatively not statistically
signiﬁcant (pN0.07) but reﬂected the direction and approximate
magnitude of fold change as observed on the expression arrays. Failure
to reach statistical signiﬁcance in these cases may be either due toas represented by the dye swap color coding below the tree, with the red bar and tree
lumn is the array of an individual animal brain. Red represents up-regulation and green
atal day one (P1) arrays. Condition tree is on the top each heat map with each dye-set
heat map.
Table 1
Genes at developmental stage E15 showing fold change ≥1.3 and pb0.005 in Agtr2−/y brains.
Probe set Genebank Gene symbol Gene description P value Fold change
A_51_P514139 NM_027504 Prdm16 PR domain containing 16 1.97E-04 +3.1
A_52_P546610 NM_013626 Pam Peptidylglycine alpha-amidating monooxygenase 6.72E-05 +2.1
A_51_P337944 NM_080708 Bmp2k BMP2 inducible kinase 7.96E-07 +1.9
A_52_P561377 NM_145505 Fam160b1 Family with sequence similarity 160, member B1 1.88E-05 +1.9
A_52_P542860 NM_172618 Btbd9 BTB (POZ) domain containing 9 1.61E-03 +1.8
A_52_P135424 AK032599 1.45E-03 +1.6
A_52_P654624 AK005333 Pisd Phosphatidylserine decarboxylase 1.08E-04 +1.6
A_52_P342836 BC055351 Hn1l Hematological and neurological expressed 1-like 2.83E-03 +1.6
A_52_P150396 AK013803 Akirin2 Akirin 2 9.00E-05 +1.6
A_52_P54666 AK086484 Mtap2 Microtubule-associated protein 2 4.68E-04 +1.6
A_52_P188425 BC047992 Prosc Proline synthetase co-transcribed 5.66E-04 +1.5
A_51_P247114 NM_008199 H2-BL Histocompatibility 2, blastocyst 8.23E-06 +1.5
A_52_P617386 AK084084 Rab30 RAB30, member RAS oncogene family 6.86E-04 +1.5
A_51_P393161 AK049497 Scaper S phase cyclin A-associated protein in the ER 1.33E-04 +1.5
A_51_P496779 NM_194462 Akap9 A kinase (PRKA) anchor protein (yotiao) 9 1.40E-04 +1.5
A_51_P446575 AK044903 Fnbp1l Formin binding protein 1-like 2.56E-04 +1.4
A_52_P207132 AK044972 Plcxd3 Phosphatidylinositol-speciﬁc phospholipase C, X domain containing 3 5.10E-04 +1.4
A_52_P462472 XM_205178 C77370 Expressed sequence C77370 9.91E-05 +1.4
A_52_P110581 AK050558 A930011G23Rik RIKEN cDNA A930011G23 gene 1.13E-04 +1.4
A_51_P212515 NM_178726 Ppm1l Protein phosphatase 1 (formerly 2C)-like 1.55E-03 +1.4
A_51_P227866 AK030696 Tmx4 Thioredoxin-related transmembrane protein 4 2.31E-04 +1.4
A_52_P503135 NM_177054 Casc4a Cancer susceptibility candidate 4 1.47E-03 +1.4
A_52_P90101 AK036209 Atxn2 Ataxin 2 1.85E-03 +1.4
A_51_P172241 TC1312974 4.07E-05 +1.4
A_52_P660753 XM_194622 Taf1 TATA box binding protein (TBP)-associated factor 8.54E-04 +1.4
A_52_P239424 AK086122 Klf7a Kruppel-like factor 7 8.96E-04 +1.4
A_52_P424197 AK029131 Map3k2 Mitogen-activated protein kinase kinase kinase 2 4.43E-04 +1.4
A_51_P366277 BC049166 Nol8 Nucleolar protein 8 1.14E-03 +1.4
A_52_P16346 AK012005 Sla2 Src-like-adaptor 2 1.93E-04 +1.4
A_52_P268720 BC021818 Helz Helicase with zinc ﬁnger domain 2.30E-04 +1.4
A_51_P134801 XM_619483 Ankrd12 Ankyrin repeat domain 12 2.95E-04 +1.4
A_51_P308628 XM_619630 Nbeal1 Neurobeachin like 1 1.07E-03 +1.4
A_51_P128075 NM_027028 1700008P20Rik RIKEN cDNA 1700008P20 gene 1.16E-03 +1.4
A_52_P407755 AK009137 Prei4 Preimplantation protein 4 1.14E-03 +1.4
A_51_P512340 NM_019840 Pde4b Phosphodiesterase 4B, cAMP speciﬁc 1.35E-04 +1.3
A_51_P364894 NM_054089 Tgs1 Trimethylguanosine synthase homolog (S. cerevisiae) 2.90E-03 +1.3
A_52_P462171 XM_354675 Arid4a AT rich interactive domain 4A (RBP1-like) 6.96E-04 +1.3
A_51_P217878 AK043468 Mtap1b Microtubule-associated protein 1B 3.78E-04 +1.3
A_52_P167166 AK047842 Shprh SNF2 histone linker PHD RING helicase 4.26E-04 +1.3
A_52_P540045 AK083897 Dgkh Diacylglycerol kinase, eta 1.39E-03 +1.3
A_52_P289071 NM_177054 Casc4a Cancer susceptibility candidate 4 5.10E-04 +1.3
A_51_P115940 NM_172787 L3mbtl3 l(3)mbt-like 3 (Drosophila) 3.44E-04 +1.3
A_52_P5549 NM_026583 5830415L20Rik RIKEN cDNA 5830415L20 gene 1.11E-04 +1.3
A_52_P38317 AK046153 Nat5 N-acetyltransferase 5 (ARD1 homolog, S. cerevisiae) 1.36E-03 +1.3
A_51_P127215 BC003348 Sesn3 Sestrin 3 3.77E-03 +1.3
A_51_P405280 NM_033563 Klf7a Kruppel-like factor 7 (ubiquitous) 5.19E-04 +1.3
A_52_P190807 AK032690 Fam92a Family with sequence similarity 92, member A 9.75E-04 +1.3
A_52_P519538 NM_172712 Uba6 Ubiquitin-like modiﬁer activating enzyme 6 1.11E-04 +1.3
A_52_P197199 XM_139187 Pcdh9 Protocadherin 9 2.01E-04 +1.3
A_52_P521507 BC051169 Trio Triple functional domain (PTPRF interacting) 5.54E-04 +1.3
A_52_P621817 AK173240 Zfp46 Zinc ﬁnger protein 46 2.49E-04 +1.3
A_52_P651784 XM_486486 discontinued record 1.15E-04 +1.3
A_51_P349008 NM_133783 Ptges2 Prostaglandin E synthase 2 3.86E-04 −1.3
A_51_P218805 NM_212443 Gfer Growth factor, erv1 (S. cerevisiae)-like (augmenter of liver regeneration) 9.44E-04 −1.3
A_52_P108808 TC1316888 5.85E-04 −1.3
A_52_P20639 NM_023727 Rd3 Retinal degeneration 3 2.41E-04 −1.3
A_51_P506937 NM_011885 Mrps12 Mitochondrial ribosomal protein S12 5.48E-04 −1.3
A_51_P432538 NM_010395 H2-t10 Histocompatibility 2, T region locus 10 5.17E-04 −1.3
A_51_P344566 NM_011121 Plk1 Polo-like kinase 1 2.81E-05 −1.4
A_51_P272172 NM_053068 Chrac1 Chromatin accessibility complex 1 3.74E-04 −1.4
A_51_P100246 NM_145578 Ube2m Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast) 1.00E-03 −1.4
A_51_P288549 BC016255 Pla2g4b Phospholipase A2, group IVB (cytosolic) 1.54E-05 −1.7
Relative expression of genes highlighted in bold types is also checked by quantitative RT-PCR.
a Genes listed twice with two separate probes: NM_177054 (Casc4) and NM_033563 (Klf7).
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due to the small sample size (four controls and four knockouts) used
for the secondary veriﬁcation by qRT-PCR.
Functional grouping
In an attempt to uncover common functions among the dysre-
gulated genes, we classiﬁed genes into gene ontology groups. Asummary of functions for dysregulated genes in the E15 knockouts are
presented in Supplementary Table 1. The largest gene categories over-
expressed in E15 Agtr2−/y brains are transcription factors and genes
with Agtr1-related functions (Supplementary Table 1). Other cate-
gories include genes involved in microtubule and actin processing, cell
adhesion, protein transport and/or binding, nucleic acid binding,
immunity, cell cycle arrest, and ubiquitin/proteosome function. In the
E15 Agtr2−/y brains, genes predominantly involved in apoptosis, polo-
Table 2
Genes at P1 showing fold change ≥1.4 and pb0.005 in Agtr2−/y brains.
Probe Set Genebank Gene symbol Gene description P value Fold change
A_51_P222953 AK047664 Gls Glutaminase 8.890E-06 +2.2
A_52_P329105 NM_134077 Rbm26 RNA binding motif protein 26 4.510E-03 +2.1
A_52_P386075 XM_622182 LOC623078 1.040E-03 +2.1
A_51_P304449 AK031960 Add1 Adducin 1 (alpha) 1.270E-04 +2.0
A_51_P390755 AK035845 Ptprs Protein tyrosine phosphatase, receptor type, S 1.380E-04 +2.0
A_52_P654624 AK005333 Pisd Phosphatidylserine decarboxylase 3.390E-04 +1.9
A_52_P657817 AK030767 Mapk8 Mitogen-activated protein kinase 8 5.090E-04 +1.9
A_52_P368881 TC1323355 3.770E-04 +1.9
A_52_P102630 AB063319 Rian RNA imprinted and accumulated in nucleus 4.280E-04 +1.8
A_52_P320822 NM_009186 Tra2b Transformer 2 beta homolog (Drosophila) 7.950E-04 +1.8
A_52_P236097 AK017529 Sf3b3 Splicing factor 3b, subunit 3 7.340E-04 +1.8
A_52_P92213 AK089867 2210404J11Rik RIKEN cDNA 2210404J11 gene 8.570E-04 +1.7
A_52_P386468 NM_007700 Chuk Conserved helix–loop–helix ubiquitous kinase 2.200E-06 +1.7
A_52_P475033 AK088515 Usp15 Ubiquitin speciﬁc peptidase 15 9.930E-04 +1.7
A_52_P617386 AK084084 Rab30 RAB30, member RAS oncogene family 1.220E-04 +1.7
A_52_P422088 AK084846 Ptbp2 Polypyrimidine tract binding protein 2 5.190E-04 +1.7
A_52_P440027 AK014565 4632411B12Rik RIKEN cDNA 4632411B12 gene 9.200E-04 +1.6
A_52_P24835 NM_027893 Pvrl4 Poliovirus receptor-related 4 5.330E-04 +1.6
A_52_P484519 AK171368 Sept 11 Septin 11 8.820E-04 +1.6
A_52_P319752 AK046219 Nudcd3 NudC domain containing 3 4.860E-04 +1.6
A_52_P527329 AK089867 2210404J11Rik RIKEN cDNA 2210404J11 gene 8.570E-04 +1.6
A_51_P183154 AK049897 Hook1 Hook homolog 1 (Drosophila) 6.280E-04 +1.6
A_52_P955951 AK048907 Gria4 Glutamate receptor, ionotropic, AMPA4 (alpha 4) 2.170E-04 +1.6
A_52_P340618 BC030361 Eml5 Echinoderm microtubule-associated protein like 5 7.360E-04 +1.6
A_52_P323215 NM_019570 Rev1 REV1 homolog (S. cerevisiae) 3.080E-05 +1.6
A_52_P433 AK129392 Saps3 SAPS domain family, member 3 5.040E-04 +1.6
A_52_P671465 AK051363 Caprin1 Cell cycle associated protein 1 2.720E-04 +1.6
A_51_P458230 AK054427 8.970E-04 +1.6
A_52_P276412 AK011886 Atpif1 ATPase inhibitory factor 1 6.450E-04 +1.6
A_52_P620432 AK019968 Fam82b Family with sequence similarity 82, member B 6.000E-04 +1.6
A_52_P398494 XM_902635 Ankrd11 Ankyrin repeat domain 11 7.040E-04 +1.5
A_52_P113585 AK084575 Htt Huntingtin 1.000E-04 +1.5
A_52_P411015 NM_177300 B130040O20Rik RIKEN cDNA B130040O20 gene 6.150E-04 +1.5
A_52_P61903 AK014174 Chka Choline kinase alpha 4.240E-04 +1.5
A_52_P182520 BC028435 Timm9 Translocase of inner mitochondrial membrane 9 homolog (yeast) 3.110E-04 +1.5
A_52_P668157 AK011905 Ncam1 Neural cell adhesion molecule 1 8.800E-05 +1.5
A_52_P124105 AK083451 Rab14 RAB14, member RAS oncogene family 1.110E-04 +1.5
A_52_P98160 TC268598 5.940E-04 +1.5
A_52_P188026 BC051052 Ccar1 Cell division cycle and apoptosis regulator 1 3.710E-04 +1.5
A_52_P59544 AK036220 Rbm18 RNA binding motif protein 18 3.110E-04 +1.5
A_52_P72938 AK039096 AI790442 Expressed sequence AI790442 8.760E-04 +1.5
A_52_P321318 AF093677 mt-Atp6 ATP synthase 6, mitochondrial 3.140E-04 +1.5
A_52_P236607 BC066170 Ercc8 Excision repaiross-complementing rodent repair deﬁciency,
complementation group 8
3.100E-04 +1.4
A_52_P289213 BC059256 Notch2 Notch gene homolog 2 (Drosophila) 8.250E-04 +1.4
A_52_P454703 BE650851 3.580E-04 +1.4
A_51_P358256 NM_009803 Nr1i3 Nuclear receptor subfamily 1, group I, member 3 6.810E-04 +1.4
A_52_P171993 AK012463 Psmd7 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 7.320E-04 +1.4
A_52_P146848 NM_016690 Hnrpdl Heterogeneous nuclear ribonucleoprotein D-like 2.740E-04 +1.4
A_52_P237755 TC1517524 8.580E-04 +1.4
A_52_P860487 ac1158020 6.740E-04 +1.4
A_51_P122246 NM_029720 Creld2 Cysteine-rich with EGF-like domains 2 3.360E-04 −1.4
A_51_P281255 NM_016777 Nasp Nuclear autoantigenic sperm protein (histone-binding) 1.840E-04 −1.4
A_52_P576863 NM_025922 Itpa Inosine triphosphatase (nucleoside triphosphate pyrophosphatase) 8.830E-04 −1.4
A_51_P259001 NM_029814 Chmp5 Chromatin modifying protein 5 3.150E-04 −1.4
A_52_P476357 NM_016878 Dnpep Aspartyl aminopeptidase 8.290E-04 −1.4
A_52_P141786 NM_029561 Ndﬁp2 Nedd4 family interacting protein 2 3.940E-04 −1.4
A_51_P349142 NM_007991 Fbl Fibrillarin 1.640E-04 −1.4
A_51_P479802 XM_110248 Fbxo11 F-box protein 11 2.630E-05 −1.4
A_51_P125535 NM_017374 Ppp2cb Protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform 5.120E-04 −1.6
A_51_P132978 NM_010497 Idh1 Isocitrate dehydrogenase 1 (NADP+), soluble 7.520E-04 −1.6
A_51_P117226 AK046533 Zdhhc2 Zinc ﬁnger, DHHC domain containing 2 1.020E-04 −1.6
A_51_P267544 NM_013522 Frg1 FSHD region gene 1 6.180E-04 −1.6
Relative expression of genes highlighted in bold types is also checked by quantitative RT-PCR.
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erv1 (Gfer) and ubiquitin-conjugating enzyme E2M (Ube2m), were
down-regulated.
Up-regulated genes in the P1 Agtr2−/y brains were involved in
protein binding and transport, RNA processing, DNA binding,
transcription, glutamate metabolism, cell adhesion as well as
cytoskeleton and microtubule expression. A complete summary of
the categories is listed in Supplementary Table 2.Examination of the P1 down-regulated results (Supplementary
Table 2) show that some of the gene functions involved are histone
modiﬁcation (Nasp, nuclear autoantigenic sperm protein and Ppp2cb,
protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform),
nucleotidemetabolism (Itpa, inosine triphosphatase), NADP+ activity
(Idh1, isocitrate dehydrogenase 1 (NADP+) soluble), protein ubiqui-
tination (Fbxo11, F-box protein 11 and Ndﬁp2, Nedd4 family interact-
ing protein 2), rRNA processing (Frg1, FSHD region gene 1), chromatin
Table 3
Q-RT-PCR results of selected genes at E15 and postnatal day 1.
Probe ID Primary
accession
Gene Dev.
stage
Fold
change
RT-PCR fold
change
RT-PCR
p-value
a_51_P337944 NM_080708 Bmp2k E15 1.9 1.4 0.18
a_52_P654624 AK005333 Pisd E15 1.6 2.3 0.05
a_52_P407755 AK009137 Prei4 E15 1.4 1.7 0.26
a_51_P488673 NM_008143 Gnb2l1a E15 −1.3 −1.5 0.09
a_52_P404108 −1.2
a_51_P473533 L32836 Ahcya E15 −1.2 −1.7 0.01
a_51_P100246 NM_145578 Ube2m E15 −1.4 −1.2 0.22
a_52_P654624 AK005333 Pisd P1 1.9 1.7 0.02
a_52_P386468 NM_007700 Chuk P1 1.7 1.4 0.05
a_51_P304449 AK031960 Add1 P1 2.0 1.7 0.10
a_52_P671465 AK051363 Caprin1 P1 1.6 1.7 0.10
a_51_P125535 NM_017374 Ppp2cb P1 −1.6 −1.4 0.07
a_51_P267544 NM_013522 Frg1 P1 −1.6 −1.7 0.08
a Genes with fold change b−1.3 and thus are not included in Table 1.
192 T.L. Pawlowski et al. / Genomics 94 (2009) 188–195remodeling (Chmp5, chromatin modifying protein 5), and calcium ion
binding (Creld1, calcium ion binding, cysteine-rich with EGF-like
domains 1).
Pathway and network analysis
Pathway Studio (Ariadne, Rockville, MD) was used to visualize
common functions for dysregulated genes in the E15 Agtr2−/y
brains. Examining the up-regulated genes in the Agtr2−/y E15 brains
with 1.3 fold or greater expression revealed a complex picture.
Among the up-regulated genes, microtubule-associated protein 2
(Mtap2), microtubule-associated protein 1B (Mtap1B), A kinase
(PRKA) anchor protein (Akap9), formin binding protein 1-like
(Fnbp1l), triple functional domain (Trio) and Src-like-adaptor 2
(Sla2) are all associated with microtubule, actin and cytoskeleton
function (Fig. 2A). Agtr2 has previously been shown to down-
regulate MAP1B (Mtap1b) but up-regulate MAP2 (Mtap2) in PC12W
cells [20]. In this study, Mtap2 and Mtap1b are both up-regulated in
the E15 Agtr2−/y brains. MAP2 has previously been shown to be
phosphorylated by JNK and subsequently deﬁnes dendritic shape in
the brain [21]. MAP2 is found in dendrites and is crucial for
microtubule stability [22]. Mtap1b is found in growth cones and is
needed for neurite outgrowth [20]. These genes also regulate actin
along with Fnbp1l and Sla2 genes [23] which are up-regulated in E15
Agtr2−/y brain. Genes involved in regulation of microtubules,
adducin 1 (alpha) (Add1), echinoderm microtubule-associated
protein like 5 (Eml5), Huntingtin (Htt), hook homolog 1 (Hook1),
NudC domain containing 3 (Nudcd3) and septin 11 (Sept11), are also
well represented in the over-expressed genes of the P1 knockouts.
Map kinase 8 (Mapk8) (also known as JNK1) is part of the Agtr1
signaling cascade and is one of the most signiﬁcantly up-regulated
genes in the P1 knockout brains. It has been shown to be a regulator
of morphogenesis in early nervous system development [24]. JNK1
phosphorylates the microtubule depolymerizing factor SCG10
which determines microtubule stability and axodendritic length
[24].
The up-regulation of conserved helix–loop–helix ubiquitous kinase
(Chuk) (also known as IKK1) in the P1 brains is signiﬁcant in that it is
also inﬂuenced by angiotensin II [25], and activates the NF-kappa-B
complex, which in turn causes cell proliferation and anti-apoptotic
effects [26]. Notch gene homolog 2 (Notch2) and Htt are up-regulated
in P1 knockouts and both have anti-apoptotic effects [27–29]. Htt up-
regulates brain derived neurotrophic factor (BDNF) [30] and associates
with the epidermal growth factor (EGF) pathway, potentially causing
over-growth of neuronal cells. Notch2 is also negatively associated
with glial differentiation [31].
Consistent with previous ﬁndings that Agtr2 induces apoptosis,
three genes down-regulated in E15 Agtr2−/y brains, Ptges2, histocom-patibility 2, T region locus 10 (H2-T10) and Ube2m, are all involved in
inducing apoptosis.
In the P1 knockouts several over-expressed genes, AMPA-selective
glutamate receptor 4 (Gria4), glutaminase (Gls) and Htt, were found
to be involved in glutamate metabolism. Glutamate metabolism is
integral to NMDA receptors which are essential in neuronal develop-
ment and synaptic plasticity.
Other important up-regulated genes in the P1 list are the cell
adhesion genes (Ncam1, Gria4, nuclear receptor subfamily 1, group I,
member 3 (Nr1i3) andMapk8). Ncam1, neural cell adhesion molecule
1, has been associated with NMDA receptors [32] and the inhibition of
cell death [33]. Poliovirus receptor-related 4 (Pvrl4) is also a cell to cell
adhesion gene [34]. Ncam1, Gria4, Nr1i3 and Mapk8 all share several
important neurological functions (Fig. 2B).
Discussion
Cognitive function and adaptive behavior are two major functions
of the brain that are consistently found to be impaired at variable
levels in people with intellectual disability. Several genes, when
defective, have been identiﬁed that cause learning and memory
impairment in humans and mice. A role for Agtr2 in brain develop-
ment and function has been suggested and a likely involvement of
AGTR2 in human ID has been previously shown [2–6]. A detailed
examination in Agtr2-deﬁcient mice further revealed a deﬁcit in
spatial memory that was not related to fear [7,8]. These mice have
demonstrated cellular over-growth in all examined brain regions [35].
Importantly, these mice showed abnormal dendritic spine morphol-
ogy and length [9]. Both features are also found in some cases of ID.
Thus, these mice provided a model system for studying genes whose
function might be dependent or inﬂuenced by Agtr2 gene function.
Expression of Agtr2 has been shown to be variable and transient in
various brain structures during embryogenesis with expression
declining rapidly after birth [13,22]. We conﬁrmed expression of the
Agtr2 gene at the E15 stage of mouse embryonic brain and chose to
use this developmental stage to study the impact of Agtr2 gene action.
We examined expression levels of 44,000 probes representing
approximately 25,000 genes in Agtr2−/y and control mouse brains at
developmental stage E15 and at birth (P1). Signiﬁcant differences in
gene expression were demonstrated by hierarchical clustering and
t-test analyses. Agtr2−/y samples grouped together and were distinct
from control samples.
Expression proﬁles of Agtr2−/y brains also shed light on possible
cellular mechanisms and genes that might be contributing to the
cognitive impairment and defective dendriticmorphology observed in
these mice [9]. These mice had altered spine morphology in areas of
CA1, including stubby, enlarged spine formation, aberrant protrusions,
and hydropic spine degeneration [9]. Dendritic spines and their
morphological plasticity play a critical role in learning and memory
function of the brain. Many forms of ID have been shown to be
associated with abnormalities in dendritic spine morphology and
structure [10–12,36]. The structure and dynamics of these structures
have been shown to be inﬂuenced by the underlying actin-
cytoskeleton and microtubules. Thus the expression levels of genes
regulating these structures are likely to play a critical role. Similar
ﬁndings were previously reported in Fmr-1 knockout mice [12].
Interestingly, several genes up-regulated in Agtr2−/y brains are
involved in cytoskeleton and microtubule regulation. The over-
expression of these genes may potentially lead to alterations in the
actin-cytoskeleton and dendritic spine seen in Agtr2−/y mouse brains.
Several genes involved in apoptosis were down-regulated in E15
Agtr2−/y brains which support a role for Agtr2 as a mediator of
apoptosis. Consistently, genes involved in anti-apoptosis activities
were up-regulated in P1 Agtr2/y brains and may reﬂect the increase in
the number of neuronal cells observed in adult Agtr2−/y mice brain
regions [35].
Fig. 2. Pathway analysis of selected up-regulated transcripts in Agtr2−/y brains. (A) Transcripts up-regulated in Agtr2−/y embryo brains are involved in pathways affecting
microtubules, actin and cytoskeleton expression as well as other cell functions vital to brain development and function. Genes highlighted in red are from the E15 list. (B) Genes with
common neurological functions are up-regulated in P1 knockouts. Red shapes=genes from P1 list. Makp8, Ncam, Nri3 and Gria4 have interactions with many ligands, transcription
factors and protein kinases in common. Down-stream effects of these up-regulated transcripts have many effects on neurological functions such as synaptic transmission and
regulation as well as cell proliferation and differentiation.
193T.L. Pawlowski et al. / Genomics 94 (2009) 188–195Surprisingly only two dysregulated genes, Pisd and Rab30, were
found in common between the two developmental stages. Signiﬁ-
cance of this observation is not clear. However, differences in
expression of Agtr2 inﬂuenced genes at two different time points of
brain development may relate to the observed variation in Agtr2 gene
expression during embryogenesis [13,22].
Activation of Agtr2 has been shown to negatively regulate some of
the actions of Agtr1 [37]. The absence of Agtr2 did not cause increased
expression of Agtr1 in the brains of E15 or P1 Agtr2−/ymice. Therewas
also no difference in the expression of several genes in the RAS
between knockouts and controls (data not shown). However, our
results show that genes downstream of Agtr1 are up-regulated in the
absence of Agtr2.
Previous studies have indicated involvement of Agtr2 in various
signaling cascades inﬂuencing neurite outgrowth and elongation,
neuronal differentiation, cell proliferation, growth inhibition and
induction of apoptosis [20,38–41]. Furthermore, Agtr2 has also been
shown to directly interact with a variety of proteins, ERBB3, ZBTB16,SLC9A6/NHE6 and MTUS1 [15–18]. Thus it is not surprising that our
study revealed a great variety of Agtr2 inﬂuenced genes. However, a
detailed mechanism of Agtr2 actions remains to be elucidated and it is
conceivable that some of the Agtr2 effects are likely direct and others
may be indirect.
The data in this study provide a ﬁrst glimpse of the gene
expression proﬁle of developing and newborn brains in the absence
of Agtr2 expression. Although it would be premature to propose a
direct link between genes dysregulated in Agtr2−/y brain and
observed features in Agtr2−/y mice, the data provide clues to these
functional correlations and can be examined further by additional
experimental means. Expression proﬁling using speciﬁc brain
regions or at additional developmental stages may reveal critical
genes that may have been masked in our analyses of whole brain.
Further studies may reveal that dysregulation of expression of
some of the genes inﬂuenced by Agtr2 may contribute either directly
or through other factors to the pathophysiology of intellectual
disability.
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Animals
Agtr2−/y mice were described previously [3,9] and are from the
129/sv strain on a C57BL/6×129 mixed genetic background with a
disrupted Agtr2 gene. Pre-dissected organs from Agtr2−/y and control
mice were isolated from the breeding stocks maintained at the
Charité, Campus Benjamin Franklin, Berlin, Germany. Experiments
were conducted according to the guidelines of the National Act on Use
of Experimental Animals of the German Federal State [9].
Animal genotyping was performed after isolating liver DNA using
the Qiagen DNA tissue kit (Qiagen Inc., Valencia, CA) according to
manufacturer's recommendation andwas used for animal genotyping.
PCR was performed with the following primer sets: knockout-
NeoPvu-F, 5′-GGCAGCGCGGCTATCGTGG-3′ and control AT25-F, 5′-
CCACCAGCAGAAACATTACC-3′ and the same reverse primer was used
for both: AT23-R, 5′-GAACTACATAAGATGCTTGCCAGG-3′. The cycling
conditionswere: 95 °C for 5min followed by 30 cycles of 95 °C for 30 s,
60 °C for 30 s and 72 °C for 45 s, with a ﬁnal extension of 7 min. Sex
was determined by genotyping with an X-linked gene Jarid1 C, using
the following primers: Forward, 5′-CTGAAGCTTTTGGCTTTGAG-3′ and
reverse, 5′-CCACTGCCAAATTCTTTGG-3′ with the following condi-
tions: initial denaturation at 95 °C for 5 min, followed by 20 s at 95 °C,
30 s at 56 °C, and 40 s at 72 °C for 30 cycles with a ﬁnal extension at
72 °C for 7 min [42]. Jarid1 C primers produced a 331 bp (chromosome
X-speciﬁc fragment) and 302 bp (speciﬁc to a homologue to Jarid1 C
on the Y chromosome) DNA fragments in males and a single 331 bp
DNA fragment in females.
RNA extraction, cDNA synthesis and array hybridization
Total RNA was extracted from frozen whole brain samples
weighing less than 30 μg using the Qiagen RNeasy kit (Qiagen Inc.,
Valencia, CA) according to the manufacturer's instructions. Samples
were cleaned with DNase using the Ambion Turbo DNase-free kit
(Ambion Inc., Austin, TX). RNA samples were analyzed on the Agilent
2100 expert bioanalyzer (Agilent, Santa Clara, CA) for purity and
concentration.
RNA from six male controls and eight male knockouts at stage E15
were ampliﬁed individually and labeled with the Agilent low RNA
Input Linear Ampliﬁcation Kit (Agilent, Santa Clara, CA) according to
the manufacturer's instructions. In brief, cDNA was synthesized using
a T7 primer and was then labeled with Cy3- or Cy5-CTP. Samples were
puriﬁed with Qiagen RNasey mini spin columns (Qiagen, Valencia,
CA). Equal amounts of control sample and Agtr2−/y sample were
labeled with Cy3 or Cy5 respectively and were hybridized to the ﬁrst
set of 8 Agilent Whole Mouse Genome Oligo 44K Microarrays slides
(Agilent, Santa Clara, CA) according to themanufacturer's protocol. On
the second set of microarray slides, the control samples were paired
with a different knockout sample. Arrays were hybridized for 17 h at
65 °C and thenwashedwith 6× SSC, 0.005% Triton X-102 for 1min and
thenwith 0.1× SSC, 0.005% Triton X-102 for 1 min and then for 30 s in
ozone scavenging solution (Agilent #5185–5979). The microarray
slides were scanned on an Agilent microarray scanner and data was
normalized and extracted with Feature Extraction 8.0 software
(Agilent, Santa Clara, CA). RNA from four male control and four P1
Agtr2−/y brains was handled in the same fashion, with all controls
being dye-swapped with a different knockout in each dye selection.
Microarray analysis
MIAME-compliant microarray data ﬁles are located on the GEO site
at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=jnwbzu-
cukeckkbs and acc =GSE12412 (project accession # GSE12412). Two
arrays from the E15 set were not included due to poor hybridization.The data sets were ﬁrst ﬁltered for probes that had a presence in at
least 50% of the arrays using dye swap as a parameter. This left 33,583
probes in the E15 data set and 32,974 probes in the P1 data set. Both
data sets were then ﬁltered by an absolute fold change of 2 fold
(log10) or greater between knockouts and controls as determined by
GeneSpring GX (Agilent, Santa Clara, CA). This ﬁltering produced a list
of 313 probes in the E15 set and 1340 probes in the P1 set. This data
was then subject to a Student's t-test with a p-value≤0.005 (which
compared favorably to a similar test with a Benjamini and Hochberg
False-Discovery rate of ≤0.01). This analysis led to an E15 list of 133
probes and a P1 list of 397 probes. Fold change (log2) was then
calculated using limma [43,44]. The lists were further narrowed
by using the most signiﬁcant probes by fold change as determined
by limma to a list of 62 transcripts for the E15 set and a similar number
of transcripts for the P1 stage. Fold change (log2) threshold values
of 1.3 and 1.4 as determined by limmawere chosen for the E15 and P1
list respectively to generate a more focused set of genes for further
analysis.
Hierarchical clustering (condition tree and gene tree) of the E15
and P1 arrays was performed by GeneSpring GX using a Pearson
correlation with a clustering algorithm=average linkage, with a
separation ratio of 1 and a minimum distance of 0.001 using the E15
or P1 ﬁnal list.
Quantitative RT-PCR
RNAwas isolated as previously described on four controls and four
knockouts from each developmental stage, and from animals not used
in themicroarray experiment previously. Primerswere designed using
the Primer3 program (http://frodo.wi.mit.edu/cgi-bin/primer3/
primer3_www.cgi) [45]. Biorad I-Script 1 step RT-PCR with SYBR
green (Biorad, Hercules, CA) was used according to manufacturer
instructions with 5 ng of RNA per sample used. Samples were run in
triplicate on a Biorad i-cycler and analyzed using a standard curve
method [46] and normalized to a control gene. The control gene,
AK029535 (Riken cDNA493050c13) was selected from a list of genes
showing the least difference in expression generated by limma using
the model 1a algorithm as described earlier [47]. The list of primers
used is in Supplementary Table 3. After normalization to the control
gene, themean log2 expression ratio for knockouts was divided by the
same for controls, to arrive at the fold change. Two-tailed t-tests
were implemented to determine signiﬁcance of changes between the
two groups.
Functional grouping, annotation and pathway analysis
Annotation of genes in the list was enhanced by using the DAVID
Gene Id Conversion Tool with a p-value threshold of ≤0.05 [48]. Gene
ontology for genes in the ﬁnal lists was also enhanced individually
investigating the gene ontology information provided by the Entrez
Gene search tool of NCBI.
Pathway Studio (Ariadne Genomics, Rockville, MD) was utilized by
loading each up- or down-regulated list and using the shortest path
function. This software builds a network from information available
from curated databases. This information is used to draw functional
relationships between proteins, cell objects, small molecules, diseases
and cell processes.
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